Antara fenofibrate regulatory update

Lupin said FDA approved an sNDA for 30 and 90 mg strengths of Antara fenofibrate as an adjunct treatment for hypercholesterolemia, mixed dyslipidemia and hypertriglyceridemia in combination with diet....